Skip to content
akaturk Academic measurement
2025 SJR Q1 JCR Q2 · 3,3 63 matched articles SCIE

Journal detail

Journal of Human Hypertension

Publisher
Springer Nature
Country
United Kingdom · Western Europe
Type
journal
ISSN
  • 09509240
  • 14765527
Scopus 1,109 SJR
Scopus Q1 SJR Q
WoS Q2 JCR Q
WoS 3,3 JIF
Scopus 113 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 1,109
  • Quartile Q1
  • H-Index 113
  • Cites/doc 3,28
  • Docs (3y) 431
  • Cites (3y) 1.364

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q2
  • JIF 3,3
  • 5Y JIF 3
  • JCI 0,7

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

  • Internal Medicine Q1

Areas

  • Medicine

WoS categories

  • Peripheral Vascular Diseases

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q1 Q2 1,109 3,3 3 0,7 Q2 113
2024 Q2 Q2 0,937 3,4 2,8 0,61 Q2 110
2023 Q2 Q2 0,753 2,7 2,6 0,54 Q2 110
2022 Q2 Q3 0,723 2,7 2,9 0,5 Q3 110
2021 Q2 Q3 0,698 2,9 2,9 0,52 Q3 110
2020 Q2 Q3 0,737 3 2,9 0,57 Q3 110
2019 Q2 Q3 0,76 2,3 2,3 0,57 Q3 110
2018 — Q3 — 1,9 2,3 0,61 Q2 —
2017 Q2 Q3 1,107 2,4 2,5 0,7 Q2 110
2016 Q2 Q3 1,053 2,8 2,4 — — 110
2015 Q1 Q2 1,205 2,8 2,6 — — 110
2014 Q1 Q2 0,987 2,7 2,6 — — 110
2013 Q1 Q2 1,209 2,7 2,4 — — 110
2012 Q1 Q2 1,08 2,8 2,5 — — 110
2011 Q1 Q2 0,938 2,8 2,2 — — 110
2010 Q2 Q3 0,723 2,2 2,1 — — 110
2009 — Q2 — 2,3 2,2 — — —
2008 — Q2 — 2,6 2,6 — — —
2007 — Q2 — 2,2 2,1 — — —
2006 — Q2 — 3 — — — —
2005 — Q2 — 2,4 — — — —
2004 — Q2 — 1,9 — — — —
2003 — Q3 — 1,4 — — — —
2002 — Q3 — 1,4 — — — —
2001 — Q2 — 1,7 — — — —
2000 — Q3 — 1,6 — — — —
1999 — Q3 — 1,2 — — — —
1998 — Q3 — 0,7 — — — —
1997 — Q3 — 0,8 — — — —

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 PERIPHERAL VASCULAR DISEASE SCIE Q2 Q2 33/100
2024 PERIPHERAL VASCULAR DISEASE SCIE Q2 Q2 27/98
2023 PERIPHERAL VASCULAR DISEASE SCIE Q2 Q2 34/96
2022 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 42/68
2021 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 44/67
2020 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 33/65
2019 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 37/65
2018 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q2 43/65
2017 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q2 38/65
2016 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 33/63
2015 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 30/63
2014 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 29/60
2013 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 30/65
2012 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 26/68
2011 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 23/68
2010 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 35/68
2009 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 30/61
2008 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 25/56
2007 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 26/54
2006 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 18/52
2005 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 22/51
2004 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 24/51
2003 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 28/52
2002 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 28/52
2001 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 25/50
2000 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 23/45
1999 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 26/44
1998 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 28/39
1997 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 22/38